Showing results (381-390 of 391) with videos related to
Sort By:
Pageof 40
Nature|June 23, 2012
The landscape of cancer genes and mutational processes in breast cancerPhilip J Stephens, Patrick S Tarpey, Helen Davies, et al.Science (New York, N.Y.)|August 2, 2014
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomesJose M C Tubio, Yilong Li, Young Seok Ju, et al.Nature|August 16, 2013
Signatures of mutational processes in human cancerLudmil B Alexandrov, Serena Nik-Zainal, David C Wedge, et al.The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.Nature|January 20, 2019
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequencesSerena Nik-Zainal, Helen Davies, Johan Staaf, et al.Nature|May 3, 2016
Landscape of somatic mutations in 560 breast cancer whole-genome sequencesSerena Nik-Zainal, Helen Davies, Johan Staaf, et al.NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.The Journal of Pathology|August 23, 2023
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJeppe Thagaard, Glenn Broeckx, David B Page, et al.Pageof 40